← All trials
NCT05003492
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2021
- Primary completion
- Oct 31, 2021
- Completion date
- Nov 30, 2021
- First posted
- Aug 12, 2021
- Last posted
- Sep 24, 2021
- Enrollment
- 2
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Government of Saudi ArabiaLead sponsor
- Government of Saudi ArabiaSponsor investigator
- Damitta UniversityOverall official - principal investigator
- Government of Saudi ArabiaOverall official - principal investigator
- Kafrelsheikh UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.